- Vast potential of mushroom medicine market is hindered by lack of pharma-grade extracts preventing brands from seizing this market opportunity
- Traditional extract producers limited by low-volume, non-scalable manufacturing methods
- Pure Extracts equipped to produce urgently needed pharma-grade psilocybin
Pure Extracts, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is in a unique position to become the dominant extraction company and a leader in the rapid development and commercialization of functional medicine products. With its substantial experience and technical competence in plant extraction creating a distinctive competitive advantage, Pure Extracts is focused on becoming a critical partner with companies developing powerful mushroom products.
As a growing body of research substantiates that psilocybin offers benefits in the treatment of depression, PTSD, anxiety, bi-polar, drug and alcohol addiction, obesity, narcolepsy, OCD, Alzheimer’s and ADHD, an increasing number of companies are looking into expanding into this space to develop products to treat these conditions (http://nnw.fm/CxwUU). However, those companies lack the high purity psilocybin compounds required for the requisite clinical trials and research needed to harness the power of this global market.
Few companies in the extraction space can deliver on this urgent need. Most providers in the space are unable to develop pharmaceutical-grade compounds because their manufacturing methods are low volume and non-scalable. This has created a significant gap in the market and presents a tremendous growth opportunity for companies designed to seize it. This is where Pure Extracts steps in.
Pure Extracts provides high-grade extracts for functional mushroom products such as tinctures and soft gels with the plan to roll out beverage formulations, nasal and oral sprays, as well as psilocybin extracts by H1 2021 H1 2021 (http://nnw.fm/JbB45). Determined to leverage the momentum of the psychedelic and functional mushroom industries as one of the fastest-growing sectors in North America, Pure Extracts represents a unique value proposition in this expanding sector that requires extraction for product development.
With its proven expertise and EU Good Manufacturing Practices (“GMP”) designed facility for licensed extraction, Pure Extracts offers a clear competitive advantage. In a space where product purity is equal to product quality, the Company employs the most technologically advanced equipment required for full-spectrum CO2 extraction, a novel process for extracting the essence of the source material where the gas helps to extract oils of high-grade purity from the biomass. As the first of its kind, Pure Extracts is a nationally recognized brand that leverages five years of volatile plant molecule extraction experience and expertise in creating a number of successful CPG products with proven processes for delivering superior extracts.
Pure Extracts has ambitious plans to leverage its competitive advantage beyond North America and place itself as an extraction manufacturer of choice for functional and psychedelic medicine companies across the world. The company plans to apply for a Dealer’s License with Health Canada, which will enable it to produce extracts of the highest quality for clinical trials in an EU GMP environment, fueling its overseas expansion.
In addition, Pure Extracts’ location within the highly regarded Canadian regulatory framework allows for easy export from Canada to destinations across the world. This enables the Company to position itself as a natural international partner for psychedelic and functional product companies looking for pharmaceutical-grade psilocybin for their clinical trials and research.
For more information, visit the company’s website at www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://nnw.fm/Pure
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.
No comments:
Post a Comment